Esmo.org - SEO Checker

¡Registrarme gratis! Exportar PDF
Visión general del análisis SEO
Metadatos
100% 
Calidad de la página
47% 
Estructura
58% 
Enlazado
11% 
Servidor
100% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
0,10 s
Tamaño HTML
340,00 kB
Palabras
4178
Medios
26
Cantidad de enlaces
448 internos / 36 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
European Society for Medical Oncology
La longitud del título es óptima (355 píxeles de una longitud máxima de 580 píxeles).
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
La longitud de la meta descripción es óptima (944 píxeles de una longitud máxima de 1000 píxeles).
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://www.esmo.org/
La página tiene una redirección canónica correcta.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en-gb
Ubicación geográfica del servidor: Estados Unidos de América
El idioma ha sido correctamente declarado en el código HTML: en-gb.
Enlaces Alternate/Hreflang
(Poco importante)
No se ha encontrado ningún enlace alternativo (alternate) en esta página.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
copyrightESMO
authorESMO
keywordsmedical oncology,oncologists,oncology societies,oncology conferences,europe
descriptionESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
generatoreZ Platform powered by Netgen
viewportwidth=device-width, initial-scale=1.0, maximum-scale=1
norton-safeweb-site-verificationn2ygvjh9mxjj82z9-mte778jumy0erkkd7zxsvx7ps8mpqx4avfdqnwqcw9dvfcmta5hjtjeya4vwcgxzq52gv3kdxnunzhimdkkks2zl39icco8x7d45ihmrkklqfc4
facebook-domain-verification3eeragwmlcd46ur5vkwb776r9jtxte
msvalidate.01BDC2955EF05146A4D0BC9BE3E6DF32BD
langen-gb
og:typewebsite
og:titleESMO
og:descriptionESMO
og:imagehttps://www.esmo.org/bundles/app/images/esmo_opengraph.png
charsetutf-8

¡Analiza ya gratis hasta 1.000 páginas de esmo.org!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Calidad de la página

Contenido
(Extremadamente importante)
El contenido de esta página es demasiado extenso (4178 palabras). Tal vez podrías dividirlo en varias páginas según el tema.
Hay 6 textos duplicados en esta página:
  • Texto duplicado 1: It is intended for the treatment of adult patients with relapsed or re...
  • Texto duplicado 2: In the MARIPOSA study, a significant improvement in progression-free s...
  • Texto duplicado 3: New indication concerns a combination with durvalumab for the maintena...
La cantidad media de palabras por frase es elevada: 71.88 palabras.
Un 26.3% del contenido está constituido por palabras vacías.
Las palabras clave del título también se repiten en el texto del cuerpo.
Las palabras del encabezado H1 también aparecen en el cuerpo del texto.
La página contiene un listado, lo que indica una buena estructuración del contenido.
Se han encontrado 46 párrafos en esta página.
No se detecta ningún placeholder de texto ni imagen.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
No se ha especificado ningún icono de Apple Touch.
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1.0, maximum-scale=1).
Etiquetas Bold y Strong
(Poco importante)
Algunas etiquetas de negritas son demasiado largas (más de 70 caracteres). Con 118 caracteres:
"oops, you're using an old version of your browser so some of the features on this page may not be disp...".
Optimización de imágenes
(Poco importante)
La descripción del atributo ALT se utiliza correctamente en todas las imágenes rastreadas.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
...age/30169140e251db563e46719de7ec91e4.svgESMO
...inoma-esmo-euracan-1000x250-july_i30.jpgESMO-Webinar-Series-Nasopharyngeal-Carcinoma-ESMO-EURACAN-1000x250-July
...tatic-non-small-cell-lung-cancer_i30.jpgESMO-Clinical-Practice-Guidelines-1000x250-Oncogene-Addicted-Metastatic-Non-Small-Cell-Lung-Cancer
...ceptorship-lung-cancer-1000x1000_i30.jpgESMO-Preceptorship-Lung-Cancer-1000x1000
...torship-gastric-cancer-1000x1000_i30.jpgESMO-Preceptorship-Gastric-Cancer-1000x1000
...795-3-eng-GB/esmo-mcbs-1000x1000_i30.jpgESMO-MCBS 1000x1000
...ients-with-the-best-care-options_i30.jpgProvide your patients with the best care options.
...es/4397014-1-eng-GB/esmo-courses_i30.jpgESMO Courses
...-1-eng-GB/esmo-oncology-journals_i30.jpgESMO Oncology Journals
...ns/4396970-1-eng-GB/publications_i30.jpgPublications
...t-course-valencia-2024-1000x1000_i30.jpgESMO-Medical-Student-Course-Valencia-2024-1000x1000
...ptorship-breast-cancer-1000x1000_i30.jpgESMO-Preceptorship-Breast-Cancer-1000x1000
...o-academy-meeting-2024-1000x1000_i30.jpgESMO-Academy-Meeting-2024-1000x1000
...ent-course-naples-2024-1000x1000_i30.jpgESMO-Medical-Student-Course-Naples-2024-1000x1000
...-courses-breast-cancer-1000x1000_i30.jpgESMO-Advanced-Courses-Breast-Cancer-1000x1000
...-GB/esmo-congress-2024-1000x1000_i30.jpgESMO-Congress-2024-1000x1000
...ip-ovarian-cancer-2024-1000x1000_i30.jpgESMO-Preceptorship-Ovarian-Cancer-2024-1000x1000
...torship-gastric-cancer-1000x1000_i30.jpgESMO-Preceptorship-Gastric-Cancer-1000x1000
...lecular-cancer-biology-1000x1000_i30.jpgESMO-Preceptorship-Molecular Cancer Biology-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
...o-advanced-courses-adc-1000x1000_i30.jpgESMO-Advanced-Courses-ADC-1000x1000
URL del VídeoAnchoAlto
https://www.youtube.com/embed/ybpRSarS2TY770433
https://www.youtube.com/embed/iPoTPdElxtU770433
https://www.youtube.com/embed/d1ZiZbh8mOk770433

Estructura de la página

Encabezado H1
(Extremadamente importante)
European Society For Medical Oncology
El encabezado H1 es óptimo.
Encabezados
(Importante)
Algunos de los encabezados H se repiten dos veces.
Hay 100 encabezados H en esta página. La cantidad de encabezados debería guardar una mejor proporción en relación al texto.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 European Society For Medical Oncology
H2 ESMO Immuno-Oncology Congress 2024
H2 Nasopharyngeal Carcinoma Webinar
H2 ESMO Oncogene-Addicted mNSCLC Living Guideline
H2 ESMO Asia 2024
H2 Molecular Analysis for Precision Oncology Congress 2024
H2 ESMO Preceptorship on Lung Cancer, 15-16 November 2024, Paris, France
H2 ESMO Preceptorship Course on Gastric Cancer, 4-5 December 2024, Singapore
H2 ESMO-MCBS
H2 July ESMO Virtual Plenary
H2 Latest News
H2 Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
H2 EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab
H2 Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC
H2 FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
H2 First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC
H2 One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer
H2 Patient Guide in Bladder Cancer Now Available Also in Greek
H2 EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer
H2 PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
H2 Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy Texto duplicado
H2 EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab Texto duplicado
H2 Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC Texto duplicado
H2 FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Texto duplicado
H2 One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer Texto duplicado
H2 EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer Texto duplicado
H2 PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL Texto duplicado
H2 FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated Advanced Colorectal Cancer
H2 Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy than Chemotherapy in Patients with Recurrent Cervical Cancer
H2 Prevention and Early Detection of Gastrointestinal Cancers Take on New Importance Amidst a Younger Population
H2 Cross-Border Network of European Specialists Provides New Treatment Options For Women with Complex Rare Gynaecological Cancers
H2 ESMO Gastrointestinal Cancers Congress 2024 Munich, Germany, 26-29 June
H2 ESMO Gynaecological Cancers Congress 2024, 20-22 June, Florence, Italy
H2 World No Tobacco Day 2024: European Societies call for an EU Endgame on Tobacco
H2 Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with High-risk Genes
H2 ESMO Breast Cancer 2024, 15-17 May, Berlin, Germany
H2 European Lung Cancer Congress 2024, 20-23 March, Prague, Czech Republic
H2 ESMO Sarcoma and Rare Cancers Congress 2024, 14-16 March, Lugano, Switzerland
H2 ESMO Calls for Urgent Action at Both EU and National Levels to Safeguard the Future of Oncological Research in Europe
H2 ESMO Journals Have Maintained Strong Impact Factors
H2 New ESMO President 2027-2028 Elected
H2 Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
H2 Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive
H2 2024 ESMO Breast Cancer Award Recipient Announced
H2 2024 Heine H. Hansen Award Recipient Announced
H2 Nomination Process for the 2024 ESMO Society Awards Now Open 
H2 ESMO Committees and Working Groups: New Chair Appointments
H2 First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC Texto duplicado
H2 Eftilagimod alpha plus pembrolizumab shows promise in HNSCC with negative PD-1 expression
H2 How to interpret genomic testing results? ESMO recommendations to make reports easy to read
H2 Oncologists do not feel well-prepared to address the health needs of LGBTQ cancer patients
H2 Doublet immunotherapy consolidates its role in hepatocellular carcinoma
H2 Ten years of improvement in the treatment of liver cancer
H2 Growing evidence supports the use of ctDNA as a biomarker in colon cancer
H2 Harnessing the power of the gut microbiome in colorectal cancer
H2 Liver transplantation plus chemotherapy prolongs survival in patients with definitively unresectable colorectal liver metastases
H2 Education
H2 Provide your patients with the best care options.
H2 ESMO Courses
H2 ESMO Oncology Journals
H2 Publications
H2 Next Meetings
H2 ESMO Course in Medical Oncology for Medical Students Valencia 2024
H2 ESMO Preceptorship on Breast Cancer 2024: Munich
H2 ESMO Academy 2024
H2 ESMO Course in Medical Oncology for Medical Students Naples 2024
H2 ESMO Advanced Course on Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative in Breast Cancer 2024: Jeddah
H2 ESMO Congress 2024
H2 ESMO Preceptorship on Ovarian Cancer 2024: Lisbon
H2 ESMO Preceptorship on Gastric Cancer 2024: Lisbon
H2 ESMO Preceptorship on Practising Oncology: Dealing with Special Strategies, Patient Populations and Toxicities 2024: Lugano
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Zurich
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and GU Cancers 2024: Singapore
H2 ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Singapore
H2 Video Gallery
H2 ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.
H2 ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity
H2 ESMO Virtual Mentorship Programme
H2 ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition
H2 ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition Texto duplicado
H2 #ESMO24: F. André, R. Dent, M. Garassino, M. Van der Heijden & M. Lambertini invite you to attend
H2 Precision Medicine in Prostate Cancer
H2 ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region
H2 Unlock your future: Why Young Oncologists should attend MAP 2024
H2 Recommendations for the use of NGS in patients with metastatic cancer
H2 Precision oncology experts on why you should submit your abstract for MAP 2024
H2 Why you should submit your abstract for MAP 2024
H2 Career Development
H2 Improve your career path
H2 Are you looking for a fellowship not offered by ESMO or would like to post a fellowship?
H2 ESMO Examination
H2 Thinking of applying for an ESMO Oncology Fellowship?
H2 Become a Member
H3 Membership
H4 172
H4 35k +
H4 40+
H5 Legal
H5 Useful links
H5 Subscribe to ESMO newsletters
Hay demasiados enlaces internos (448) en esta página.
Algunos textos ancla son demasiado largos.
Algunos enlaces internos contienen parámetros dinámicos. Las URL internas no deberían contener parámetros dinámicos, salvo que estén marcadas como nofollow.
Algunos textos ancla se repiten más de una vez en varios enlaces.
Hay 1 links con un texto ancla que no es suficientemente relevante.
Hay demasiados enlaces externos (36) en esta página.

Enlaces detectados en esta página

EnlacePropiedadesTexto ancla
https://www.google.com/chrome/Nueva ventana Externo Subdominio Google Chrome 24+
https://www.mozilla.org/en-US/...Nueva ventana Externo Subdominio Mozilla Firefox 20+
https://www.microsoft.com/en-u...Nueva ventana Externo Subdominio Internet Explorer 11
https://www.opera.com/downloadNueva ventana Externo Subdominio Opera 15–18
https://www.apple.com/safari/Nueva ventana Externo Subdominio Apple Safari 7
https://www.seamonkey-project....Nueva ventana Externo Subdominio SeaMonkey 2.15-2.23
https://www.esmo.org/Subdominio ESMO
/meeting-calendarSubdominio Meeting Calendar
https://oncologypro.esmo.org/Externo Subdominio OncologyPRO
/membership/join-esmoSubdominio Become a member
https://www.esmo.org/saml/loginLogin
https://www.esmo.org/Subdominio Texto duplicado IMG-ALT ESMO
A-TITLE ESMO
/membership/member-benefitsSubdominio Benefits of an ESMO Membership
https://www.esmo.org/about-esmoSubdominio Who we are
/about-esmo/how-we-workSubdominio How we work
/about-esmo/esmo-valuesSubdominio Our values
https://www.esmo.org/Subdominio Texto duplicado ESMO
/meeting-calendarSubdominio Texto duplicado Meeting Calendar
https://oncologypro.esmo.org/Externo Subdominio Texto duplicado OncologyPRO
https://www.esmo.org/about-esmoSubdominio About ESMO
A-TITLE About ESMO
/about-esmo/esmo-vision-2025Subdominio ESMO Vision 2025
/about-esmo/esmo-vision-2025/o...Subdominio One Oncology Community
/about-esmo/esmo-vision-2025/e...Subdominio Education for Life
/about-esmo/esmo-vision-2025/a...Subdominio Accessible Cancer Care
/about-esmo/esmo-missionSubdominio ESMO Mission
/about-esmo/esmo-valuesSubdominio ESMO Values
/about-esmo/awardsSubdominio Awards
/about-esmo/awards/esmo-award-...Subdominio ESMO Award Nominations
/about-esmo/awards/fellow-of-e...Subdominio Fellow of ESMO (FESMO)
/about-esmo/awards/fellow-of-e...Subdominio FESMO 2022
/about-esmo/awards/esmo-awardSubdominio ESMO Award
/about-esmo/awards/esmo-award-...Subdominio ESMO Award for Translational Research
/about-esmo/awards/esmo-women-...Subdominio ESMO Women for Oncology Award
/about-esmo/awards/esmo-lifeti...Subdominio ESMO Lifetime Achievement Award
/about-esmo/awards/esmo-breast...Subdominio ESMO Breast Cancer Award
/about-esmo/awards/heine-h.-ha...Subdominio Heine H. Hansen Award
/about-esmo/awards/esmo-award-...Subdominio ESMO Award for Immuno-Oncology
/about-esmo/awards/tat-honorar...Subdominio TAT Honorary Award
/about-esmo/organisational-str...Subdominio Organisational Structure
/about-esmo/organisational-str...Subdominio ESMO Council
/about-esmo/organisational-str...Subdominio Executive Board
/about-esmo/organisational-str...Subdominio Annals of Oncology Editorial Board
/about-esmo/organisational-str...Subdominio Audit Committee
/about-esmo/organisational-str...Subdominio Cancer Medicines Committee
/about-esmo/organisational-str...Subdominio Compliance Committee
/about-esmo/organisational-str...Subdominio Educational Committee
/about-esmo/organisational-str...Subdominio Adolescents and Young Adults Working Group
/about-esmo/organisational-str...Subdominio Designated Centres Working Group
/about-esmo/organisational-str...Subdominio Educational Publications Working Group
/about-esmo/organisational-str...Subdominio ESMO Faculty
/about-esmo/organisational-str...Subdominio ESMO SIOG Cancer in the Elderly Working Group
/about-esmo/organisational-str...Subdominio Examination & Accreditation Working Group
/about-esmo/organisational-str...Subdominio OncologyPRO Working Group
/about-esmo/organisational-str...Subdominio Practising Oncologists Working Group
/about-esmo/organisational-str...Subdominio Real World Data and Digital Health Working Group
/about-esmo/organisational-str...Subdominio Translational Research and Precision Medicine Working Group
/about-esmo/organisational-str...Subdominio Texto duplicado ESMO Faculty
/about-esmo/organisational-str...Subdominio ESMO Open Editorial Board
/about-esmo/organisational-str...Subdominio Guidelines Committee
/about-esmo/organisational-str...Subdominio ESMO-Magnitude of Clinical Benefit Scale Working Group
/about-esmo/organisational-str...Subdominio Major Achievements
/about-esmo/organisational-str...Subdominio IOTECH Editorial Board
/about-esmo/organisational-str...Subdominio Leadership Development Committee
/about-esmo/organisational-str...Subdominio Membership Committee
/about-esmo/organisational-str...Subdominio National Societies Committee
/about-esmo/organisational-str...Subdominio Nomination Committee
/about-esmo/organisational-str...Subdominio Communication Committee
/about-esmo/organisational-str...Subdominio Women for Oncology Committee
/about-esmo/organisational-str...Subdominio Young Oncologists Committee
/about-esmo/organisational-str...Subdominio Texto duplicado Major Achievements
/about-esmo/organisational-str...Subdominio ESMO Members: Get Involved
/about-esmo/organisational-str...Subdominio ESMO Committees: Application Form
/about-esmo/organisational-str...Subdominio Editor-in-Chief Of ESMO Rare Cancers
/about-esmo/organisational-str...Subdominio OPWG Open Call for Members
/about-esmo/organisational-str...Subdominio ESMO Task Forces
/about-esmo/organisational-str...Subdominio ESMO Gender Medicine Task Force
/about-esmo/organisational-str...Subdominio Climate Change Task Force
/about-esmo/organisational-str...Subdominio Resilience Task Force
/about-esmo/organisational-str...Subdominio ESMO Clinical Research Observatory Task Force (ECRO)
/about-esmo/how-we-workSubdominio Texto duplicado How we work
/about-esmo/how-we-work/declar...Subdominio Declaration of Interest
/about-esmo/how-we-work/declar...Subdominio EFPIA Disclosure Code
/about-esmo/how-we-work/esmo-e...Subdominio ESMO Presidential Election: 2027-2028
/about-esmo/how-we-work/esmo-e...Subdominio ESMO Elections FAQ
/about-esmo/how-we-work/esmo-s...Subdominio ESMO Structure
/about-esmo/how-we-work/code-o...Subdominio Code of Conduct
/about-esmo/how-we-work/esmo-a...Subdominio ESMO Annual Report
/about-esmo/how-we-work/esmo-f...Subdominio ESMO Funding
/about-esmo/how-we-work/esmo-f...Subdominio 2022 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2019 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2020 Funding Sources
/about-esmo/how-we-work/esmo-f...Subdominio 2021 Funding Sources
/about-esmo/how-we-work/bylawsSubdominio ESMO Bylaws
/about-esmo/how-we-work/esmo-g...Subdominio General Assembly
/about-esmo/how-we-work/esmo-g...Subdominio Notification of 2023 ESMO General Assembly Vote
/about-esmo/biographiesSubdominio Biographies
/about-esmo/careers-at-esmoSubdominio Careers at ESMO
/about-esmo/discover-esmo-jour...Subdominio Discover ESMO Journals
/about-esmo/discover-esmo-jour...Subdominio Annals of Oncology
/about-esmo/discover-esmo-jour...Subdominio About Annals of Oncology
/about-esmo/discover-esmo-jour...Subdominio ESMO Open
/about-esmo/discover-esmo-jour...Subdominio Frequently Asked Questions
/about-esmo/discover-esmo-jour...Subdominio Immuno-Oncology and Technology
/about-esmo/discover-esmo-jour...Subdominio ESMO Gastrointestinal Oncology
/about-esmo/discover-esmo-jour...Subdominio ESMO Real World Data and Digital Oncology
/about-esmo/discover-esmo-jour...Subdominio ESMO Affiliated Journals
/about-esmo/discover-esmo-jour...Subdominio Cancer Treatment Reviews
/about-esmo/discover-esmo-jour...Subdominio Clinical Lymphoma Myeloma and Leukemia
/about-esmo/discover-esmo-jour...Subdominio Lung Cancer
/about-esmo/discover-esmo-jour...Subdominio The Breast
/about-esmo/discover-esmo-jour...Subdominio COVID-19 and cancer care in the ESMO journals
/about-esmo/esmo-brandSubdominio ESMO Brand
/about-esmo/esmo-brand/esmo-logoSubdominio ESMO Logo
/about-esmo/collaborate-with-esmoSubdominio Collaborate with ESMO
/about-esmo/collaborate-with-e...Subdominio Texto duplicado Frequently Asked Questions
/about-esmo/president-letterSubdominio President Letter
/about-esmo/president-letter/s...Subdominio Stepping into the shoes of a Society with a global footprint
/about-esmo/president-letter/e...Subdominio Embracing a year of strong collaboration and steady progress
/about-esmo/joining-forcesSubdominio Joining Forces
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2024
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2023
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2022
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2021
/about-esmo/joining-forces/esm...Subdominio ESMO for World Cancer Day 2020
/about-esmo/contact-usSubdominio Contact Us
https://www.esmo.org/membershipSubdominio Membership
A-TITLE Membership
/membership/join-esmoSubdominio Join ESMO
/membership/member-benefitsSubdominio Member Benefits
/membership/membership-categor...Subdominio Membership Categories & Annual Fees
/membership/esmo-in-your-countrySubdominio ESMO in Your Country
https://www.esmo.org/guidelinesSubdominio Guidelines
A-TITLE Guidelines
/guidelines/guidelines-by-topicSubdominio Guidelines by topic
/guidelines/guidelines-by-topi...Subdominio Breast Cancer
/guidelines/guidelines-by-topi...Subdominio Cancers of Unknown Primary Site
/guidelines/guidelines-by-topi...Subdominio Endocrine and Neuroendocrine Cancers
/guidelines/guidelines-by-topi...Subdominio Gastrointestinal Cancers
/guidelines/guidelines-by-topi...Subdominio Genitourinary Cancers
/guidelines/guidelines-by-topi...Subdominio Gynaecological Cancers
/guidelines/guidelines-by-topi...Subdominio Haematological Malignancies
/guidelines/guidelines-by-topi...Subdominio Head and Neck Cancers
/guidelines/guidelines-by-topi...Subdominio Hereditary Syndromes
/guidelines/guidelines-by-topi...Subdominio Lung and Chest Tumours
/guidelines/guidelines-by-topi...Subdominio Melanoma and Skin Cancers
/guidelines/guidelines-by-topi...Subdominio Neuro-Oncology
/guidelines/guidelines-by-topi...Subdominio Sarcoma and GIST
/guidelines/guidelines-by-topi...Subdominio Supportive and Palliative Care
/guidelines/guidelines-newsSubdominio Guidelines News
/guidelines/esmo-expert-consen...Subdominio ESMO Expert Consensus Statements
/guidelines/pagaSubdominio Pan-Asian Guidelines Adaptation (PAGA)
/guidelines/esmo-guidelines-me...Subdominio ESMO Guidelines Methodology
/guidelines/pocket-guidelines-...Subdominio Pocket Guidelines & Mobile App
/guidelines/pocket-guidelines-...Subdominio Translated ESMO Pocket Guidelines
/guidelines/guidelines-slide-setsSubdominio Guidelines Slide Sets
/guidelines/cancer-patient-man...Subdominio Cancer Patient Management During the COVID-19 Pandemic
/guidelines/cancer-patient-man...Subdominio Disclaimer
/guidelines/cancer-patient-man...Subdominio Primary brain tumours in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Gastrointestinal cancers: Hepatocellular carcinoma (HCC) in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Genitourinary cancers: Urothelial cancer of the bladder in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Genitourinary cancers: Renal cell cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Genitourinary cancers: Prostate cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Gynaecological malignancies: Cervical cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Gynaecological malignancies: Endometrial cancer in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: DLBCL, MCL and Aggressive T-cell lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: Hodgkin lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: Indolent B-NHL in the second phase of the COVID-19 pandemic (ESMO-EHA)
/guidelines/cancer-patient-man...Subdominio Haematological malignancies: Multiple myeloma in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Head and neck cancers in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Melanoma in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Sarcomas in the COVID-19 era
/guidelines/cancer-patient-man...Subdominio Supportive Care in the COVID-19 era
/guidelines/covid-19-palliativ...Subdominio COVID-19 Palliative Care Pathways
/guidelines/q-a-on-covid-19Subdominio Q&A on COVID-19
/guidelines/covid-19-adapted-r...Subdominio COVID-19 adapted recommendations Slide Sets
/guidelines/esmo-mcbsSubdominio ESMO-MCBS
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS in Action
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS sessions at ESMO 2020
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS Online Tutorials
/guidelines/esmo-mcbs/about-th...Subdominio About the ESMO-MCBS
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS Terms of Use
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS for Haematological Malignancies
/guidelines/esmo-mcbs/esmo-mcb...Subdominio ESMO-MCBS for Solid Tumours
/about-esmo-meetingsSubdominio Meetings
A-TITLE Meetings
/meeting-calendarSubdominio Texto duplicado Meeting Calendar
/meeting-calendar/past-meetingsSubdominio Past Meetings
/about-esmo-meetings/esmo-cong...Subdominio ESMO Congresses
/about-esmo-meetings/esmo-virt...Subdominio ESMO Virtual Plenaries
/about-esmo-meetings/esmo-virt...Subdominio Sponsors
/about-esmo-meetings/esmo-virt...Subdominio Abstracts
/about-esmo-meetings/esmo-virt...Subdominio FAQs
/about-esmo-meetings/esmo-academySubdominio ESMO Academy
/about-esmo-meetings/esmo-adva...Subdominio ESMO Advanced Courses
/about-esmo-meetings/esmo-adva...Subdominio Texto duplicado FAQs
/about-esmo-meetings/esmo-adva...Subdominio Acknowledgements
/about-esmo-meetings/esmo-adva...Subdominio Testimonials
/about-esmo-meetings/esmo-prec...Subdominio ESMO Preceptorship Courses
/about-esmo-meetings/esmo-prec...Subdominio Texto duplicado Acknowledgements
/about-esmo-meetings/esmo-prec...Subdominio Texto duplicado FAQs
/about-esmo-meetings/esmo-prec...Subdominio Texto duplicado Testimonials
/about-esmo-meetings/esmo-summitsSubdominio ESMO Summits
/about-esmo-meetings/esmo-summ...Subdominio Texto duplicado Testimonials
/about-esmo-meetings/esmo-cour...Subdominio ESMO Courses in Medical Oncology for Medical Students
/about-esmo-meetings/esmo-cour...Subdominio ESMO Best Student Award
/about-esmo-meetings/esmo-cour...Subdominio Texto duplicado Testimonials
/about-esmo-meetings/eso-esmo-...Subdominio ESO-ESMO Masterclasses
/about-esmo-meetings/esmo-symp...Subdominio ESMO Symposia
/about-esmo-meetings/esmo-coll...Subdominio ESMO Colloquia
/about-esmo-meetings/esmo-webi...Subdominio ESMO Webinar Series
/about-esmo-meetings/workshops...Subdominio Workshops
/about-esmo-meetings/esmo-even...Subdominio ESMO Events App
/about-esmo-meetings/esmo-even...Subdominio How to Use the App
/about-esmo-meetings/esmo-lice...Subdominio ESMO Licensed Events
/career-developmentSubdominio Career Development
A-TITLE Career development
/career-development/oncology-f...Subdominio Oncology Fellowships
/career-development/oncology-f...Subdominio Host Institutes
/career-development/oncology-f...Subdominio Host an ESMO Fellow
/career-development/oncology-f...Subdominio Fellowship Offers
/career-development/oncology-f...Subdominio Benefits for Institutes
/career-development/oncology-f...Subdominio Awardees and Reports
/career-development/oncology-f...Subdominio External Oncology Fellowship Opportunities
/career-development/oncology-f...Subdominio About Oncology Fellowships
/career-development/resilience...Subdominio Texto duplicado Resilience Task Force
/career-development/resilience...Subdominio ESMO Resilience Task Force: Survey Series
/career-development/young-onco...Subdominio Young Oncologists Corner
/career-development/young-onco...Subdominio Young Oncologists Track
/career-development/young-onco...Subdominio YO4YO Virtual Session Series
/career-development/young-onco...Subdominio About Young Oncologists Corner
/career-development/young-onco...Subdominio National Activities
/career-development/young-onco...Subdominio Considering a Career Abroad?
/career-development/esmo-exami...Subdominio ESMO Examination
/career-development/esmo-exami...Subdominio Parallel Sessions
/career-development/esmo-exami...Subdominio Why Sit the ESMO Exam?
/career-development/esmo-exami...Subdominio ESMO Exam Talent Pool
/career-development/esmo-exami...Subdominio Sample Exam Questions Explained
/career-development/esmo-exami...Subdominio Best Exam Award
/career-development/recertific...Subdominio Recertification & CME
/career-development/recertific...Subdominio ESMO-MORA Recertification Process and Requirements
/career-development/recertific...Subdominio CME Tests for Handbooks
/career-development/esmo-certi...Subdominio ESMO Certificate of Professional Development
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Advanced Courses
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Preceptorship Courses
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Webinar Series
/career-development/esmo-certi...Subdominio Texto duplicado ESMO Virtual Plenaries
/career-development/jobs-in-on...Subdominio Jobs in Oncology
/career-development/women-for-...Subdominio Women for Oncology
/career-development/women-for-...Subdominio ESMO W4O Observatory
/career-development/women-for-...Subdominio W4O Hub
/career-development/women-for-...Subdominio Resource Centre
/career-development/women-for-...Subdominio W4O Sessions and Events
/career-development/leaders-ge...Subdominio Leaders Generation Programme
/career-development/leaders-ge...Subdominio Class of 2021-2022
/career-development/leaders-ge...Subdominio Class of 2016
/career-development/leaders-ge...Subdominio Class of 2017
/career-development/leaders-ge...Subdominio Class of 2018
/career-development/leaders-ge...Subdominio Class of 2019
/career-development/leaders-ge...Subdominio Leaders Generation Programme Asia
/career-development/leaders-ge...Subdominio Texto duplicado Class of 2019
/career-development/leaders-ge...Subdominio Class of 2022
/career-development/travel-gra...Subdominio Travel Grants for ESMO Meetings
/career-development/about-care...Subdominio About Career Development
/scales-and-toolsSubdominio Scales and Tools
A-TITLE Scales and Tools
/scales-and-tools/esmo-guidanc...Subdominio ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW)
/scales-and-tools/esmo-scale-f...Subdominio ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
/scales-and-tools/esmo-mcbsSubdominio Texto duplicado ESMO-MCBS
https://www.esmo.org/researchSubdominio Research
A-TITLE Research
/research/about-the-grant-schemesSubdominio About the Grant Schemes
/research/esmo-clinical-resear...Subdominio Texto duplicado ESMO Clinical Research Observatory Task Force (ECRO)
/research/esmo-clinical-resear...Subdominio Acknowledgements: Rationalizing Bureaucracy
/research/esmo-clinical-resear...Subdominio Bibliography on Clinical Trial Procedures
/research/research-funding-opp...Subdominio Research Funding opportunities
/research/research-funding-opp...Subdominio ESMO Webinar: EU Research Opportunities
/research/research-funding-opp...Subdominio How to Apply For EU Grants
/research/research-funding-opp...Subdominio EU Calls for Proposals
/research/research-funding-opp...Subdominio Training and Events
/research/research-funding-opp...Subdominio Regulatory Information
/research/research-funding-opp...Subdominio Other Research Funding Opportunities
/research/research-groups-tool...Subdominio Research Groups, Tools and Database
/research/research-groups-tool...Subdominio General research groups
/research/research-groups-tool...Subdominio Cancer research groups by type
/research/research-groups-tool...Subdominio Databases
/research/research-groups-tool...Subdominio Research tools
/research/registries-studies-a...Subdominio COVID-19 and Cancer: Registries, Studies and Surveys
/research/registries-studies-a...Subdominio ESMO-CoCARE Registry
https://www.esmo.org/for-patientsSubdominio For Patients
A-TITLE Patients
/for-patients/resources-for-ca...Subdominio Resources for Patients with Cancer
/for-patients/esmo-designated-...Subdominio ESMO Designated Centres of Integrated Oncology and Palliative Care
/for-patients/esmo-designated-...Subdominio Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris
/for-patients/esmo-designated-...Subdominio How to re-accredit?
/for-patients/esmo-designated-...Subdominio Texto duplicado Designated Centres Working Group
/for-patients/esmo-designated-...Subdominio Palliative and Supportive Care Sessions at ESMO Congress 2023 Madrid
/for-patients/esmo-designated-...Subdominio 2023 ESMO Designated Centres
/for-patients/cancer-care-duri...Subdominio Cancer Care During the COVID-19 Pandemic
/for-patients/cancer-care-duri...Subdominio Multiple Myeloma
/for-patients/cancer-care-duri...Subdominio Melanoma
/for-patients/cancer-care-duri...Subdominio Sarcoma
/for-patients/cancer-care-duri...Subdominio Krebstherapie während der COVID-19-Pandemie
/for-patients/cancer-care-duri...Subdominio Renal Cell Carcinoma
/for-patients/cancer-care-duri...Subdominio Prostate Cancer
/for-patients/cancer-care-duri...Subdominio Pancreatic Cancer
/for-patients/cancer-care-duri...Subdominio Texto duplicado Lung Cancer
/for-patients/cancer-care-duri...Subdominio Ovarian Cancer
/for-patients/cancer-care-duri...Subdominio Palliative Care Glossary
/for-patients/cancer-care-duri...Subdominio Supportive Care Glossary
/for-patients/cancer-care-duri...Subdominio Gastro-Oesophageal Cancer
/for-patients/cancer-care-duri...Subdominio Hepatocellular Carcinoma
/for-patients/cancer-care-duri...Subdominio Endometrial Cancer
/for-patients/cancer-care-duri...Subdominio Colorectal Cancer
/for-patients/cancer-care-duri...Subdominio Primary Brain Tumour
/for-patients/cancer-care-duri...Subdominio Aggressive Lymphoma Management
/for-patients/cancer-care-duri...Subdominio Texto duplicado Breast Cancer
/for-patients/cancer-care-duri...Subdominio B-cell non-Hodgkin Lymphoma
/for-patients/cancer-care-duri...Subdominio Urothelial Bladder Cancer
/for-patients/cancer-care-duri...Subdominio Hodgkin Lymphoma
/for-patients/cancer-care-duri...Subdominio Cervical Cancer
/for-patients/cancer-care-duri...Subdominio Traitement du Cancer au Cours de la Pandémie de COVID-19
/for-patients/cancer-care-duri...Subdominio Le Cure per il Cancro Durante la Pandemia da COVID-19
/for-patients/cancer-care-duri...Subdominio Cuidado del cáncer durante la pandemia de COVID-19
/for-patients/cancer-care-duri...Subdominio Glossary
/for-patients/patient-advocate...Subdominio Patient Advocates Working Group
/for-patients/patient-advocacy...Subdominio Patient Advocacy Track
/for-patients/patient-guidesSubdominio Patient Guides
/for-patients/patient-guides/p...Subdominio Patient Guides by Language
/for-patients/patient-guides/b...Subdominio Bone Health in Cancer
/for-patients/patient-guides/p...Subdominio Immunotherapy Side Effects
/for-patients/patient-guides/s...Subdominio Survivorship
/for-patients/patient-guides/c...Subdominio Cancer Pain Management
/for-patients/patient-guides/p...Subdominio Personalised Cancer Medicine
/for-patients/personalised-med...Subdominio Personalised Medicine Explained
/for-patients/getting-the-most...Subdominio Getting the Most out of Your Oncologist
/for-patients/esmo-patient-eng...Subdominio ESMO Patient Engagement Summit
https://www.esmo.org/policySubdominio Policy
A-TITLE Policy
/policy/esmo-manifestoSubdominio ESMO Manifesto
/policy/policy-newsSubdominio Policy News
/policy/esmo-public-policy-com...Subdominio Public Policy Committee
/policy/patient-advocates-work...Subdominio Texto duplicado Patient Advocates Working Group
/policy/cancer-medicines-commi...Subdominio Texto duplicado Cancer Medicines Committee
/policy/esmo-public-policy-tra...Subdominio ESMO Public Policy Track and Special Sessions
https://www.esmo.org/newsroomSubdominio Newsroom
A-TITLE Newsroom
/newsroom/press-and-media-hubSubdominio Press and Media Hub
https://dailyreporter.esmo.org/Nueva ventana Nofollow Externo Subdominio ESMO Daily Reporter
/oncology-newsSubdominio Oncology News
A-TITLE Oncology News
/newsroom/esmo-society-updatesSubdominio ESMO Society Updates
/membership/join-esmoSubdominio Texto duplicado Become a member
https://www.esmo.org/saml/loginTexto duplicado Login
/meeting-calendar/esmo-immuno-...Subdominio ESMO Immuno-Oncology Congress 2024
/meeting-calendar/esmo-immuno-...Subdominio Submit your abstract
/meeting-calendar/esmo-guideli...Nueva ventana Subdominio IMG-ALT ESMO-Webinar-Series-Nasopharyngeal-Carcinoma-ESMO-EURACAN-1000x250-July
/meeting-calendar/esmo-guideli...Subdominio Nasopharyngeal Carcinoma Webinar
/meeting-calendar/esmo-guideli...Subdominio Register Now
/living-guidelines/esmo-oncoge...Nueva ventana Subdominio IMG-ALT ESMO-Clinical-Practice-Guidelines-1000x250-Oncogene-Addicted-Metastatic-Non-Small-Cell-Lung-Cancer
/living-guidelines/esmo-oncoge...Subdominio ESMO Oncogene-Addicted mNSCLC Living Guideline
/living-guidelines/esmo-oncoge...Subdominio To the Guideline
/meeting-calendar/esmo-asia-co...Subdominio ESMO Asia 2024
/meeting-calendar/esmo-asia-co...Subdominio Sign up before 4 September
/meeting-calendar/molecular-an...Subdominio Molecular Analysis for Precision Oncology Congress 2024
/meeting-calendar/molecular-an...Subdominio Submit your abstract by 23 July!
/meeting-calendar/esmo-precept...Nueva ventana Subdominio IMG-ALT ESMO-Preceptorship-Lung-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Lung Cancer, 15-16 November 2024, Paris, France
/meeting-calendar/esmo-precept...Subdominio Apply now!
/meeting-calendar/esmo-precept...Nueva ventana Subdominio IMG-ALT ESMO-Preceptorship-Gastric-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship Course on Gastric Cancer, 4-5 December 2024, Singapore
/meeting-calendar/esmo-precept...Subdominio Texto duplicado Apply now!
/guidelines/esmo-mcbsNueva ventana Subdominio IMG-ALT ESMO-MCBS 1000x1000
/guidelines/esmo-mcbsSubdominio Texto duplicado ESMO-MCBS
/guidelines/esmo-mcbsSubdominio Discover more
https://oncologypro.esmo.org/m...Externo Subdominio July ESMO Virtual Plenary
https://oncologypro.esmo.org/m...Externo Subdominio  Watch Now
/oncology-news/development-of-...Subdominio Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
/oncology-news/ema-recommends-...Subdominio EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab
/oncology-news/entrectinib-is-...Subdominio Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC
/oncology-news/fda-approves-du...Subdominio FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
https://dailyreporter.esmo.org...Externo Subdominio First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC
/oncology-news/one-year-of-adj...Subdominio One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer
/for-patients/patient-guides/b...Subdominio Patient Guide in Bladder Cancer Now Available Also in Greek
/oncology-news/ema-recommends-...Subdominio EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer
/oncology-news/pet-2-guided-br...Subdominio PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
/oncology-newsSubdominio More Oncology News
/newsroom/press-and-media-hub/...Subdominio More Press Releases
/newsroom/esmo-society-updatesSubdominio More Society Updates
https://dailyreporter.esmo.org/Nueva ventana Externo Subdominio Read the ESMO Daily Reporter
/oncology-news/development-of-...Subdominio Texto duplicado Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
/oncology-news/ema-recommends-...Subdominio Texto duplicado EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab
/oncology-news/entrectinib-is-...Subdominio Texto duplicado Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive Advanced/Metastatic NSCLC
/oncology-news/fda-approves-du...Subdominio Texto duplicado FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer
/oncology-news/one-year-of-adj...Subdominio Texto duplicado One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among Patients with Stage I HER2-positive Breast Cancer
/oncology-news/ema-recommends-...Subdominio Texto duplicado EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with Endometrial Cancer
/oncology-news/pet-2-guided-br...Subdominio Texto duplicado PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
/oncology-news/fda-grants-acce...Subdominio FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated Advanced Colorectal Cancer
/oncology-news/second-or-third...Subdominio Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy than Chemotherapy in Patients with Recurrent Cervical Cancer
/oncology-newsSubdominio Texto duplicado More Oncology News
/newsroom/press-and-media-hub/...Subdominio Prevention and Early Detection of Gastrointestinal Cancers Take on New Importance Amidst a Younger Population
/newsroom/press-and-media-hub/...Subdominio Cross-Border Network of European Specialists Provides New Treatment Options For Women with Complex Rare Gynaecological Cancers
/newsroom/press-and-media-hub/...Subdominio ESMO Gastrointestinal Cancers Congress 2024 Munich, Germany, 26-29 June
/newsroom/press-and-media-hub/...Subdominio ESMO Gynaecological Cancers Congress 2024, 20-22 June, Florence, Italy
/newsroom/press-and-media-hub/...Subdominio World No Tobacco Day 2024: European Societies call for an EU Endgame on Tobacco
/newsroom/press-and-media-hub/...Subdominio Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with High-risk Genes
/newsroom/press-and-media-hub/...Subdominio ESMO Breast Cancer 2024, 15-17 May, Berlin, Germany
/newsroom/press-and-media-hub/...Subdominio European Lung Cancer Congress 2024, 20-23 March, Prague, Czech Republic
/newsroom/press-and-media-hub/...Subdominio ESMO Sarcoma and Rare Cancers Congress 2024, 14-16 March, Lugano, Switzerland
/newsroom/press-and-media-hub/...Subdominio Texto duplicado More Press Releases
/newsroom/esmo-society-updates...Subdominio ESMO Calls for Urgent Action at Both EU and National Levels to Safeguard the Future of Oncological Research in Europe
/newsroom/esmo-society-updates...Subdominio ESMO Journals Have Maintained Strong Impact Factors
/newsroom/esmo-society-updates...Subdominio New ESMO President 2027-2028 Elected
/newsroom/esmo-society-updates...Subdominio Three Prominent ESMO Officers Shine in News Pages for Their Accomplishments in Cancer Research
/newsroom/esmo-society-updates...Subdominio Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive
/newsroom/esmo-society-updates...Subdominio 2024 ESMO Breast Cancer Award Recipient Announced
/newsroom/esmo-society-updates...Subdominio 2024 Heine H. Hansen Award Recipient Announced
/newsroom/esmo-society-updates...Subdominio Nomination Process for the 2024 ESMO Society Awards Now Open 
/newsroom/esmo-society-updates...Subdominio ESMO Committees and Working Groups: New Chair Appointments
/newsroom/esmo-society-updatesSubdominio Texto duplicado More Society Updates
https://dailyreporter.esmo.org...Externo Subdominio Texto duplicado First-line avimantamab plus lazertinib shows efficacy in patients with high-risk EGFR-mutant advanced NSCLC
https://dailyreporter.esmo.org...Externo Subdominio Eftilagimod alpha plus pembrolizumab shows promise in HNSCC with negative PD-1 expression
https://dailyreporter.esmo.org...Externo Subdominio How to interpret genomic testing results? ESMO recommendations to make reports easy to read
https://dailyreporter.esmo.org...Externo Subdominio Oncologists do not feel well-prepared to address the health needs of LGBTQ cancer patients
https://dailyreporter.esmo.org...Externo Subdominio Doublet immunotherapy consolidates its role in hepatocellular carcinoma
https://dailyreporter.esmo.org...Externo Subdominio Ten years of improvement in the treatment of liver cancer
https://dailyreporter.esmo.org...Externo Subdominio Growing evidence supports the use of ctDNA as a biomarker in colon cancer
https://dailyreporter.esmo.org...Externo Subdominio Harnessing the power of the gut microbiome in colorectal cancer
https://dailyreporter.esmo.org...Externo Subdominio Liver transplantation plus chemotherapy prolongs survival in patients with definitively unresectable colorectal liver metastases
https://dailyreporter.esmo.org/Nueva ventana Externo Subdominio Texto duplicado Read the ESMO Daily Reporter
https://www.esmo.org/guidelinesNueva ventana Subdominio IMG-ALT Provide your patients with the best care options.
https://www.esmo.org/guidelinesSubdominio Texto duplicado Provide your patients with the best care options.
https://www.esmo.org/guidelinesSubdominio Read the guidelines
/about-esmo-meetings/esmo-prec...Subdominio Preceptorships
/about-esmo-meetings/esmo-cour...Subdominio Courses on Medical Oncology for Medical Students
/about-esmo-meetings/esmo-adva...Subdominio Advanced Courses
/about-esmo-meetings/esmo-summitsSubdominio Summits
/about-esmo/discover-esmo-jour...Nueva ventana Subdominio IMG-ALT ESMO Oncology Journals
/about-esmo/discover-esmo-jour...Subdominio Texto duplicado ESMO Oncology Journals
/about-esmo/discover-esmo-jour...Subdominio Texto duplicado Annals of Oncology
/about-esmo/discover-esmo-jour...Subdominio Texto duplicado ESMO Open
/about-esmo/discover-esmo-jour...Subdominio ESMO IO Tech
/about-esmo/discover-esmo-jour...Subdominio More about Journals
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio IMG-ALT Publications
https://oncologypro.esmo.org/e...Externo Subdominio Texto duplicado Publications
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Essentials for Clinicians
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Handbooks
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Factsheet on Biomarkers
https://oncologypro.esmo.org/e...Nueva ventana Externo Subdominio Visit the Education library
/meeting-calendar/esmo-course-...Subdominio IMG-ALT ESMO-Medical-Student-Course-Valencia-2024-1000x1000
/meeting-calendar/esmo-course-...Subdominio ESMO Course in Medical Oncology for Medical Students Valencia 2024
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Breast-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Breast Cancer 2024: Munich
/meeting-calendar/esmo-academy...Subdominio IMG-ALT ESMO-Academy-Meeting-2024-1000x1000
/meeting-calendar/esmo-academy...Subdominio ESMO Academy 2024
/meeting-calendar/esmo-course-...Subdominio IMG-ALT ESMO-Medical-Student-Course-Naples-2024-1000x1000
/meeting-calendar/esmo-course-...Subdominio ESMO Course in Medical Oncology for Medical Students Naples 2024
/meeting-calendar/esmo-advance...Subdominio IMG-ALT ESMO-Advanced-Courses-Breast-Cancer-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative in Breast Cancer 2024: Jeddah
/meeting-calendar/esmo-congres...Subdominio IMG-ALT ESMO-Congress-2024-1000x1000
/meeting-calendar/esmo-congres...Subdominio ESMO Congress 2024
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Ovarian-Cancer-2024-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Ovarian Cancer 2024: Lisbon
/meeting-calendar/esmo-precept...Subdominio Texto duplicado IMG-ALT ESMO-Preceptorship-Gastric-Cancer-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Gastric Cancer 2024: Lisbon
/meeting-calendar/esmo-precept...Subdominio IMG-ALT ESMO-Preceptorship-Molecular Cancer Biology-1000x1000
/meeting-calendar/esmo-precept...Subdominio ESMO Preceptorship on Practising Oncology: Dealing with Special Strategies, Patient Populations and Toxicities 2024: Lugano
/meeting-calendar/esmo-advance...Subdominio IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Zurich
/meeting-calendar/esmo-advance...Subdominio Texto duplicado IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and GU Cancers 2024: Singapore
/meeting-calendar/esmo-advance...Subdominio Texto duplicado IMG-ALT ESMO-Advanced-Courses-ADC-1000x1000
/meeting-calendar/esmo-advance...Subdominio ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Breast, Gynaecological and GI Cancers 2024: Singapore
/meeting-calendarSubdominio Discover all ESMO meetings
https://www.youtube.com/user/E...Externo Subdominio Watch all ESMO videos
/career-development/oncology-f...Subdominio Are you looking for a fellowship not offered by ESMO or would like to post a fellowship?
/career-development/oncology-f...Subdominio External Fellowship
/career-development/esmo-exami...Subdominio Texto duplicado ESMO Examination
/career-development/esmo-exami...Subdominio Texto ancla no relevante
Read more
/career-development/oncology-f...Subdominio Thinking of applying for an ESMO Oncology Fellowship?
/career-development/oncology-f...Subdominio Fellowship Programme
/membership/member-benefitsSubdominio Discover member benefits
https://www.esmo.org/terms-of-useSubdominio Terms of Use
/terms-of-use/privacy-policySubdominio Privacy Policy
https://www.esmo.org/about-esmoSubdominio Texto duplicado About ESMO
/about-esmo/contact-usSubdominio Texto duplicado Contact Us
https://esmo.my.site.com/myesm...Externo Subdominio Login to your ESMO account
https://www.twitter.com/myesmoNueva ventana Externo Subdominio Twitter
https://www.facebook.com/esmo.orgNueva ventana Externo Subdominio Facebook
https://www.youtube.com/user/E...Nueva ventana Externo Subdominio Youtube
/rss/feed/esmo-newsSubdominio RSS
https://www.linkedin.com/compa...Nueva ventana Externo Subdominio LinkedIn
https://www.instagram.com/esmo...Nueva ventana Externo Subdominio Instagram
https://www.esmo.org/Texto ancla Sin texto
/terms-of-use/privacy-policyNueva ventana Subdominio Texto duplicado Privacy Policy

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.esmo.org/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
Esta página utiliza GZip para la transmisión de datos comprimidos.
Rendimiento
(Poco importante)
El tiempo de respuesta de la página HTML es excelente: 0,10 segundos, y se sitúa por debajo de los 0,40 segundos.
El tamaño HTML de la página es adecuado: 340 kB.

Cabecera HTTP

NombreValor
content-typetext/html; charset=UTF-8
dateMon, 22 Jul 2024 08:56:20 GMT
content-encodinggzip
x-varnish316704387 314342048
age164
varyAccept-Encoding
cache-controlprivate, no-cache, no-store, must-revalidate
accept-rangesbytes
strict-transport-securitymax-age=16000000; preload;
statuscode200
http_versionHTTP/2

Factores externos

Listas negras
(Deseable)
Esta página no está clasificada como “contenido para adultos”.
Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 5.683 dominios de referencia.
Esta página recibe un total de 902.116 backlinks.
Esta página recibe backlinks de 4.083 direcciones IP distintas.
Popularidad en Facebook
(Poco importante)
Esta página tiene 0 compartir y comentarios en Facebook.

Backlinks desde Wikipedia

Descubre más links en la función de búsqueda de Wikipedia

Robots.txt

User-agent: *
Crawl-delay: 5
Disallow: /content/search
Disallow: /search
Disallow: /user/login
Disallow: /user/logout
Disallow: /login
Disallow: /logout
Disallow: /saml/
Disallow: /layout/
Disallow: /nglayouts/ajax/
Disallow: /myesmo/
Disallow: /Function/
Disallow: /Event-Type/
Disallow: /Term/
Disallow: /Promoted-content/
Disallow: /view-news/
Disallow: /resources/
Disallow: /useful-links/
Disallow: /no_cache/
Disallow: /fileadmin/
Disallow: /events/
Disallow: /education-research/
Disallow: /career-grants/
Disallow: /Helpdesk-Categories
Disallow: /ESMO-Members-Forum
Disallow: /Featured-articles
Disallow: /Links
Disallow: /Tests
Disallow: /_deprecated/
Disallow: /_tagging-objects/
Disallow: /_old-structure/
Disallow: /daily_reporter/
Disallow: /living-guidelines/
Disallow: /esp/
Disallow: /attendances/certificate/
Sitemap: https://www.esmo.org/sitemaps/index

User-agent: MJ12bot
Disallow: /

User-agent: AhrefsBot
Disallow: /

Páginas similares

Snippet (vista previa de los resultados de búsqueda)

www.esmo.org
European Society for Medical Oncology
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Oncology81%Check
Medical81%Check
Medical Oncology81%Check
Society Medical79%Check
Society77%Check
Europe77%Check
European Society72%Check
ESMO Oncology67%Check
European66%Check
ESMO Society65%Check
Mostrar más palabras clave

¡Analiza ya gratis hasta 1.000 páginas de esmo.org!

Registrarme Gratis
Puedes usar la suscripción Básica por tiempo ilimitado.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Aviso legal | Privacidad y Cookies

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses